ZACKS INVESTMENT MANAGEMENT - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 107 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 5.83 and the average weighting 0.2%.

Quarter-by-quarter ownership
ZACKS INVESTMENT MANAGEMENT ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q4 2021$23,000
-30.3%
12,0000.0%0.00%
-100.0%
Q3 2021$33,00012,0000.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,736,283$14,553,0006.80%
VR Adviser, LLC 16,047,286$19,899,0003.22%
COMMODORE CAPITAL LP 10,097,229$12,521,0002.80%
SPHERA FUNDS MANAGEMENT LTD. 4,951,423$6,140,0000.87%
EPIQ PARTNERS, LLC 1,161,350$1,440,0000.77%
NEA Management Company, LLC 16,302,596$20,215,0000.58%
Nicholas Investment Partners, LP 4,570,387$5,667,0000.40%
Ghost Tree Capital, LLC 1,315,154$1,631,0000.35%
Orbimed Advisors 12,909,283$16,008,0000.26%
HighVista Strategies LLC 315,880$392,0000.25%
View complete list of VISTAGEN THERAPEUTICS INC shareholders